BRE03-60
A Phase II Trial of Capecitabine and Oxaliplatin (CAPOX) in Patients With Metastatic Breast Cancer: Hoosier Oncology Group BRE03-60
For full description, see www.clinicaltrials.gov.
Linked In
You Tube
A Phase II Trial of Capecitabine and Oxaliplatin (CAPOX) in Patients With Metastatic Breast Cancer: Hoosier Oncology Group BRE03-60
For full description, see www.clinicaltrials.gov.
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter